Rephonic
Artwork for ASCO Daily News
Breast Cancer
Immunotherapy
ASCO Annual Meeting
Artificial Intelligence
Clinical Trials
Lung Cancer
Oncology
Colorectal Cancer
Multiple Myeloma
Cancer Care
Chemotherapy
Neoadjuvant Therapy
Acute Myeloid Leukemia
Prostate Cancer
Circulating Tumor DNA
Non-Small Cell Lung Cancer
Ovarian Cancer
Pembrolizumab
Targeted Therapy
Toxicities

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.

PublishesTwice monthlyEpisodes277Founded10 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for ASCO Daily News

Latest Episodes

Dr. Christine Lovly and Dr. Vamsi Velcheti discuss practice-changing lung cancer data presented at the 2026 ASCO Annual Meeting, including key studies on squamous cell lung cancer, NSCLC, and SCLC.

LINK TO FULL TRANSCRIPT

Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC.

LINK TO FULL TRANSCR... more

Dr. Monty Pal shares highlights from Day 4 of the 2026 ASCO Annual Meeting, including a much-anticipated study in hepatocellular carcinoma, new data in non–small cell lung cancer, and a key update in the treatment of Merkel cell carcinoma.

LINK TO ... more

Dr. Monty Pal shares highlights from Day 3 of the 2026 ASCO Annual Meeting, including new research for the treatment of advanced CRC and mCRPC, TIL cell therapy in advanced non-uveal melanoma, and an ultra-low dose immunotherapy trial in head and nec... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Journal of Clinical Oncology (JCO) Podcast
Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)
Two Onc Docs
Two Onc DocsSam and Karine
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)
ASCO Education
ASCO EducationAmerican Society of Clinical Oncology (ASCO)
NEJM This Week
NEJM This WeekNEJM Group

Recent Guests

Ghassan Abou-Alfa
Speaker introducing Emerald III study, MSKCC investigator
Memorial Sloan Kettering Cancer Center
Episode: Day 4: Top Takeaways From ASCO26
Janice Menert
Presenter of STAMP/LBA 9505 Merkel cell carcinoma analysis
New York University
Episode: Day 4: Top Takeaways From ASCO26
Dr. Al-Jawari
Researcher presenting ThriveMM study
Massachusetts General Hospital
Episode: Day 1: Top Takeaways From ASCO26
Jo Chien
Professor of clinical medicine and medical director of breast oncology
University of California, San Francisco; UCSF Helen Diller Family Comprehensive Cancer Center
Episode: ASCO26 Preview: Novel Therapies and Innovations in Cancer Care
Alan Karthikesalingam
Director and principal scientist at Google DeepMind; co-founder and leader of AMI and AI Co-Scientists
Google DeepMind; AMI
Episode: The Future of AI in Oncology: A Conversation With Google's AI Innovators
Anil Palepu
Research scientist at Google Research; core contributor to AMI
Google Research; AMI
Episode: The Future of AI in Oncology: A Conversation With Google's AI Innovators
Arturo Loaiza-Bonilla
System-Line Chief of Hematology and Oncology at St. Luke's University Health Network; Co-Founder and Chief Medical Officer of MassiveBio
St. Luke's University Health Network; MassiveBio
Episode: 'No Margin for Error': What to Know Before Implementing AI in Clinical Practice
Vincent Rajkumar
Lead investigator of the Aquila study; senior author on the manuscript
Mayo Clinic
Episode: Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma
Saad Usmani
Chief of the Myeloma Service at MSK and professor of medicine
Memorial Sloan Kettering Cancer Center
Episode: Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma

Host

Monty Pal
Medical Oncologist at City of Hope; frequent host of clinical oncology discussions across multiple subspecialties.

Reviews

4.7 out of 5 stars from 130 ratings
  • Accessible high yield content

    As a medical resident, I’m impressed by how this podcast is able to offer expert-driven insights into the cutting edge of oncology without losing listeners in the weeds of a highly specialized topic. These episodes are concise, charismatically delivered, and fascinating.

    Apple Podcasts
    5
    Leigh_k_k
    United States5 months ago
  • No help to practice. Agenda driven.

    None of this helps me in my practice. It seems like an agenda driven outlet with very little, if any practice changing information.

    Apple Podcasts
    1
    D0ct0r.J
    United States3 years ago
  • Advanced prostrate cancer

    Exceptional research done by these doctors and researchers- someone in my family has advanced prostrate cancer - which has moved into hip bone.

    It is so scary .

    Right now he’s on hormone therapy . To reduce the size of the gland.

    He’s 84 and is in excellent health.

    He’s in Carmel so if there are trials or anything else I’d love to pass the information on to him.

    After listening to this podcast I am excited about the novel studies /trials on the horizon .

    The fact that many cancer patie... more

    Apple Podcasts
    5
    dinar320
    United States3 years ago
  • Ask for the draft of the program

    Would you please give us the draft of this program!Thanks a lot!

    Apple Podcasts
    5
    猫小猫2009
    China6 years ago
  • Dr.James Gulley

    Thank you for this informative and reassuring podcast. The interviewer allowed Dr. Gulley lots of time to share his knowledge and asked only relevant questions. More like this please.

    Apple Podcasts
    5
    JJGeneva
    United Kingdom6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Audience appreciates in-depth guest expertise and the host's ability to elicit practical takeaways.
Listeners praise its concise, expert-driven insights into oncology advances.
Some listeners feel the content is agenda-driven and not practice-changing for their patient care.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

The Future of AI in Oncology: A Conversation With Google's AI Innovators
Q: What are the main limitations of AI in real-world, high-stakes oncology decisions?
Limitations include the need for expert human oversight, the complex balance of patient-specific factors and preferences that may not be captured fully, and the risk that AI reminders or suggestions must be delivered within careful, accountable medical decision-making frameworks.
The Future of AI in Oncology: A Conversation With Google's AI Innovators
Q: How does AMI perform in breast oncology scenarios compared to clinicians of varying experience?
In synthetic breast oncology cases, AMI performed well enough to outperform trainees and fellows in several areas, but attendings still outperformed the AI, highlighting that AI can match lower-to-mid levels of expertise while still needing refinement to reach top-tier clinical intuition.
The Future of AI in Oncology: A Conversation With Google's AI Innovators
Q: What makes AMI distinct from a standard chatbot in medical contexts?
AMI is designed with domain-specific reasoning, clinical information handling, and processes like multi-step inference, web searches for up-to-date clinical knowledge, and self-critique to adjust its outputs, making it more suitable for nuanced medical decision support than general chatbots.
'No Margin for Error': What to Know Before Implementing AI in Clinical Practice
Q: Can you tell us some of the cool stuff we might anticipate in the next year or two as it pertains to how we're using AI in oncology, radiology, and genomics?
AI is poised to enhance clinical decision support, accelerate trial matching, and improve radiology and pathology workflows, while still requiring careful governance to avoid over-reliance. The key is balancing AI-enabled efficiency with rigorous source verification, explainability, and a constant emphasis on medical judgment and patient-centered care.
Highlights From the 2026 ASCO GU Cancers Symposium
Q: With Niagara and the EV-303/EV-304 data in context, should IO-based regimens be considered for all patients, or are there specific exclusion criteria?
The discussion suggests that EV-pembrolizumab in a perioperative setting appears highly enticing and could become a new standard of care for many patients, regardless of cisplatin eligibility, though individual patient factors such as performance status and comorbidity will still guide decisions. The data support broader adoption but emphasize patient selection and toxicity management when considering IO-containing regimens.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About ASCO Daily News

What is ASCO Daily News about and what kind of topics does it cover?

A data-driven oncology podcast that surfaces expert interpretations of cutting-edge cancer research, trial results, and clinical practice implications. Episodes span breast, GU, GI, thoracic, and hematologic malignancies, with emphasis on new therapies, biomarkers, AI in oncology, trial design, and real-world implementation. Notable is a pattern of clinician-hosted discussions that translate complex studies into practical takeaways for practitioners, along with guest experts from top universities and cancer centers and occasional industry content. The show often includes practical clinical guidance, debates about evolving standards of care, and forward-looking topics like AI-assisted decision-making and access to care, making it valuable fo... more

Where can I find podcast stats for ASCO Daily News?

Rephonic provides a wide range of podcast stats for ASCO Daily News. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to ASCO Daily News and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does ASCO Daily News get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for ASCO Daily News, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for ASCO Daily News?

Rephonic provides comprehensive predictive audience data for ASCO Daily News, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does ASCO Daily News have?

To see how many followers or subscribers ASCO Daily News has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to ASCO Daily News?

These podcasts share a similar audience with ASCO Daily News:

1. Journal of Clinical Oncology (JCO) Podcast
2. Two Onc Docs
3. ASCO Guidelines
4. ASCO Education
5. NEJM This Week

How many episodes of ASCO Daily News are there?

ASCO Daily News launched 10 years ago and published 277 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact ASCO Daily News?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for ASCO Daily News?

Rephonic pulls ratings and reviews for ASCO Daily News from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for ASCO Daily News?

Rephonic provides full transcripts for episodes of ASCO Daily News. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on ASCO Daily News?

Recent guests on ASCO Daily News include:

1. Ghassan Abou-Alfa
2. Janice Menert
3. Dr. Al-Jawari
4. Jo Chien
5. Alan Karthikesalingam
6. Anil Palepu
7. Arturo Loaiza-Bonilla
8. Vincent Rajkumar

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days